SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits.

Elisa MarillyJudith CottinNatalia CabreraCatherine CornuRemy BoussageonPhilippe MoulinJean-Christophe LegaFrançois GueyffierMichel CucheratGuillaume Grenet

Published in: Diabetologia (2022)

OSF Registries: https://doi.org/10.17605/OSF.IO/J3R7Y FUNDING: This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Keyphrases

type diabetes
healthcare
glycemic control
mental health
human health
cardiovascular disease
insulin resistance
risk assessment
adverse drug
electronic health record